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Abstract
Background: The natural course of submacular hemorrhage resulting from traumatic choroidal rupture generally
has a poor outcome unless treated. The intravitreal injection of gas only or gas with recombinant tissue
plasminogen activator (rt-PA) has been reported to be effective, but has also been reported to induce severe
complications such as retinal detachment and vitreous hemorrhage. Recently, we reported a safe and effective
procedure for treating submacular hemorrhage due to polypoidal choroidal vasculopathy (PCV) with a low dose of
rt-PA. Here we report the application of this procedure to a case of traumatic submacular hemorrhage in a
13-year-old boy, which achieved a good visual outcome.
Case presentation: A 13-year-old Japanese boy presented with a thick submacular hemorrhage in his left eye as a
result of blunt trauma from being hit by a sinker. Best-corrected visual acuity (BCVA) was assessed as only able to
perceive hand motions. We carried out a vitrectomy, subretinal injection of 4,000 IU rt-PA (6.9 μg) and air
tamponade. The day after surgery, most of the submacular hemorrhage had moved to the inferior periphery. One
month after the surgery, we observed cataract formation, thin remnants of the submacular hemorrhage and
juxtafoveal choroidal rupture. We carried out cataract surgery and injected bevacizumab intravitreally to prevent the
development of choroidal neovascularization. Two months after the second surgery, the submacular hemorrhage
had totally disappeared and the patient had a BCVA of 20/40.
Conclusion: Vitrectomy, subretinal injection of rt-PA, and intravitreal air tamponade may be a promising strategy
for treating traumatic submacular hemorrhage in young patients.
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Background
Ocular blunt trauma can rupture the choroid and result
in massive submacular hemorrhage [1]. The outcomes
for untreated traumatic submacular hemorrhages have
been reported to be poor because of the resulting hema-
totoxicity, the development of choroidal neovasculariza-
tion arising from choroidal rupture, and subsequent
fibrotic degeneration of the retina and choroid [2, 3].
For patients to recover good visual acuity, surgical
intervention should be considered. To date, traumatic
submacular hemorrhage was often treated with the in-
travitreal injection of gas only or gas with recombinant
tissue plasminogen activator (rt-PA) without carrying
out a vitrectomy [4–7]. However, injecting gas into
non-vitrectomized eyes has been reported to induce se-
vere complications, such as retinal detachment and vit-
reous hemorrhage [4, 8].
Recently, we have reported that vitrectomy, subretinal
injection of rt-PA and air tamponade were effective in
treating submacular hemorrhage due to PCV [8]. This
procedure assured the safe displacement of submacular
hemorrhages, using a low dose of rt-PA. We therefore
applied the same procedure to a traumatic submacular
hemorrhage in a 13-year-old boy and achieved a good
visual outcome.
Case presentation
An otherwise healthy 13-year-old Japanese boy pre-
sented with reduced central vision in his left eye, 3 days
after suffering a blunt trauma from being hit by a fishing
sinker. Assessment of BCVA showed only the ability to
perceive hand motions in the left eye compared to 20/
13.3 in the right eye. The intraocular pressure was
8 mmHg in both eyes. The anterior segment of the left
eye showed hyphema and laceration of the bulbar con-
junctiva. No traumatic cataract or rupture of the globe
was seen. Fundus examination of the left eye showed a
subretinal hemorrhage extending from the posterior
pole to the inferior midperiphery and a slight vitreous
hemorrhage (Fig. 1a). No retinal tear or retinal detach-
ment was seen. In contrast, the right eye appeared normal.
Swept-source optical coherence tomography (OCT; DRI
OCT-1 Atlantis, Topcon Medical Systems, Tokyo, Japan)
showed the presence of a thick submacular hemorrhage
in the left eye (Fig. 1d). Attempts to measure the retinal
sensitivity using a microperimeter (MAIA; CenterVue,
Padova, Italy) failed, as it was below the detection limits
of the instrument (Fig. 1g). We therefore diagnosed sub-
macular hemorrhage in the left eye, due to choroidal
rupture following blunt trauma.
Two days after the initial visit, we carried out anterior
chamber lavage, vitrectomy, subretinal injection of rt-PA
(GRTPA®, Mitsubishi Tanabe Pharma Corporation, Japan)
and air tamponade on the left eye under general anesthesia.
This operation was performed using the methods reported
by Kimura et al. [8]. Briefly, after performing a 25-gauge
micro-incision vitrectomy, 4,000 IU rt-PA in 0.1 ml was
injected subretinally using a 38-gauge subretinal infusion
needle (MedOne, Sarasota, FL) to liquefy the submacular
hemorrhage. Before completing the operation, fluid-air ex-
change was performed. The patients remained facedown
for 3 days after surgery to displace the submacular
hemorrhage. The day after the operation, most of the sub-
macular hemorrhage had moved to the inferior periphery.
One month after the operation, the BCVA of left eye
was 20/1000 and we observed cataract formation, thin
remnants of the submacular hemorrhage and juxtafoveal
choroidal rupture (Fig. 1b and e). We then carried out
phacoemulsification and aspiration, intraocular lens im-
plantation and intravitreal injection of 0.05 ml bevacizu-
mab (Avastin®, Hoffmann-la Roche, Basel, Switzerland)
in the left eye under general anesthesia. Two months
after the second operation, the submacular hemorrhage
had totally disappeared (Fig. 1c and f) and the BCVA in
the left eye had improved to 20/40. As shown in Fig. 1h,
the retinal sensitivity had markedly improved.
Conclusions
We successfully displaced a traumatic submacular
hemorrhage in the eye of a 13-year-old boy using vi-
trectomy, the subretinal injection of 4,000 IU rt-PA,
and air tamponade. Previously, Hillenkamp et al. re-
ported a case of traumatic submacular hemorrhage in
which they injected 10–20 μg rt-PA subretinally [9].
The dose of rt-PA we used was 35–69 % of the dose
they had used and 14–28 % of the rt-PA dose which
has generally been injected subretinally to displace
submacular hemorrhage due to age related macular de-
generation or macroaneurysm [9–12]. Since rt-PA has
been reported to cause retinal toxicity, such as a de-
creased amplitude in electroretinography and atrophy
of photoreceptors [3, 12–14], it is important to care-
fully consider the dose of rt-PA used. Although the
post-operative observation period for this case has only
been 3 months, no chorioretinal atrophy or reduced
retinal sensitivity has so far been observed. Longer
term follow-up will be needed to monitor any retinal
toxicity due to rt-PA.
One month after surgery, we observed a juxtafoveal
choroidal rupture and a residual submacular hemorrhage.
We then injected bevacizumab intravitreally, to prevent
the development of choroidal neovascularization and ac-
celerate absorption of the submacular hemorrhage. Chor-
oidal rupture is known to be a major risk factor for the
development of choroidal neovascularization, with a re-
ported rate of 11.0–37.5 % [3, 13–15]. In this case, we
concerned about development of choroidal neovasculari-
zation, which was likely to directly affect visual acuity,
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because the choroidal rupture was located in the juxtafo-
veal region. Abdul-Salim et al. reported a case in which
the intravitreal injection of bevacizumab contributed to
the absorption of a submacular hemorrhage due to trau-
matic choroidal rupture [15]. They speculated that the
anti-inflammatory effect of the anti-VEGF drug promoted
the absorption of the submacular hemorrhage. Although
choroidal neovascularization has not been seen so far in
our patient, longer follow-up is needed to monitor for its
development.
At present, the treatment for submacular hemorrhage can
be broadly divided into “nonvitrectomizing techniques”
and “vitrectomizing techniques.” Both approaches have
been combined with intravitreal injection of rt-PA or anti-
VEGF or gas or a combination of these. Especially in
young patient, traumatic submacular hemorrhage may
often take a wait-and-see approach or nonvitrectomizing
techniques. Because vitrectomizing techniques for young
patient can cause severe complications such as prolifera-
tive vitreoretinopathy or rhegmatogenous retinal detach-
ment. In the past, there are a few reports for young
traumatic submacular hemorrhage. These procedures are
intravitreal injection of gas, ranivizmab, or gas and rt-PA
[6, 7, 15]. In this case, we chose vitrectomizing technique
Fig. 1 Successful displacement of a traumatic submacular hemorrhage in the left eye of a 13-year-old boy. Fundus examinations (a) before
surgery, when the best-corrected visual acuity (BCVA) was hand motions only, showing a subretinal hemorrhage extending from the posterior
pole to the inferior midperiphery (arrow indicates the thick submacular hemorrhage and arrow-heads outline its area), (b) one month after
vitrectomy, when the BCVA was 20/1000, showing the remaining thin submacular hemorrhage and juxtafoveal choroidal ruptures (arrow indicates
the submacular hemorrhage and arrow-heads indicate juxtafoveal choroidal ruptures), and (c) two months after the second operation, when the
BCVA of the left eye had improved to 20/40, showing the submacular hemorrhage had totally disappeared. Optical coherence tomography (d)
before surgery (arrow indicates the thick submacular hemorrhage), (e) one month after vitrectomy showing the remaining thin submacular
hemorrhage and juxtafoveal choroidal ruptures (arrow indicates the submacular hemorrhage and arrow-heads indicate juxtafoveal choroidal
ruptures), and (f) two months after the second operation, showing the submacular hemorrhage had totally disappeared. Retinal sensitivity
measured with a microperimeter (MAIA) (g) could not be detected before surgery, but (h) showed a marked improvement two months after
the second operation. The numbers in H indicate retinal sensitivities (dB)
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even though the patient is 13 years old young boy. Be-
cause the submacular hemorrhage is very large and
thick, so we think we can not remove this submacular
hemorrhage by nonvitrectomizing techniques only. Fur-
thermore, subretinal injection of rt-PA is efficient for
adult massive submacular hemorrhage due to PCV [8],
we selected the same procedure for this case. Fortu-
nately, submacular hemorrhage moved effectively out of
fovea and no severe complication occered except cata-
ract formation. We must take care when we are taking
vitrectomizing technique for young patient.
In summary, vitrectomy, subretinal injection of rt-PA
and air tamponade may be a promising strategy for
treating traumatic submacular hemorrhage in young pa-
tients. However, this report describes only a single case,
with a relatively short follow-up period so far, and ran-
domized controlled clinical studies involving a larger
number of patients will be needed to determine the im-
pact of this surgical procedure on the management of
traumatic subretinal hemorrhage.
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